Marc Engelhardt
Chief Tech/Sci/R&D Officer chez BASILEA PHARMACEUTICA AG
Profil
Marc Engelhardt is currently the Chief Medical Officer at Basilea Pharmaceutica AG since 2018.
Prior to this, he worked as the Director-Global Program Medical at Novartis Pharma AG.
Dr. Engelhardt completed his undergraduate and doctorate degrees at Johann Wolfgang Goethe-Universität Frankfurt am Main.
Postes actifs de Marc Engelhardt
Sociétés | Poste | Début |
---|---|---|
BASILEA PHARMACEUTICA AG | Chief Tech/Sci/R&D Officer | 01/01/2018 |
Anciens postes connus de Marc Engelhardt
Sociétés | Poste | Fin |
---|---|---|
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Formation de Marc Engelhardt
Johann Wolfgang Goethe-Universität Frankfurt am Main | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
BASILEA PHARMACEUTICA AG | Health Technology |
Entreprise privées | 1 |
---|---|
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |